State WA
Clinical Trials in Washington
Recruiting clinical trials with at least one study location in Washington. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington
NCT04928846 Phase 3
Recruiting
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Teliso...
Condition
Non Small Cell Lung Cancer
Enrollment
698 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
NCT00674388 N/A
Recruiting
The Pediatric Anesthesia Quality Improvement Project
Condition
Surgery
Enrollment
5,000,000 pts
Location
United States
Sponsor
The Society for Pediatric Anes
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT02468024 Phase 3
Recruiting
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR)...
Condition
Non-Small Cell Lung Cancer
Enrollment
272 pts
Location
United States, Australia, Canada
Sponsor
University of Texas Southweste
NCT06067841 Phase 1
Recruiting
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistan...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
140 pts
Location
United States
Sponsor
Bristol-Myers Squibb
NCT07105007 N/A
Recruiting
Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Heal...
Condition
HIV
Enrollment
30 pts
Location
United States, Brazil
Sponsor
University of Washington
NCT06541704 Phase 3
Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With ...
Condition
Age-related Macular Degeneration (AMD)
Enrollment
975 pts
Location
United States, Austria, Canada
Sponsor
Regeneron Pharmaceuticals
NCT03513614 N/A
Recruiting
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followe...
Condition
Node-positive Breast Cancer
Enrollment
1,500 pts
Location
United States, Argentina, Austria
Sponsor
University Hospital, Basel, Sw
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Canada
Sponsor
Olema Pharmaceuticals, Inc.
NCT07044336 Phase 3
Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected End...
Condition
Endometrial Cancer
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06690398 Phase 3
Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated W...
Condition
Irritability Associated With Autism Spectrum Disorder
Enrollment
174 pts
Location
United States
Sponsor
Intra-Cellular Therapies, Inc.
NCT03334292 N/A
Recruiting
Natural History of Wilson Disease
Condition
Wilson Disease
Enrollment
300 pts
Location
United States, Germany, United Kingdom
Sponsor
Yale University
NCT04669171 Phase 1, Phase 2
Recruiting
A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Pat...
Condition
Follicular Lymphoma
Enrollment
80 pts
Location
United States, France, Italy
Sponsor
Enterome
NCT06934239 Phase 4
Recruiting
A Trial Comparing Screening Mammography With and Without Assistance From Artific...
Condition
Breast Cancer Screening
Enrollment
400,000 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
NCT06937229 Phase 3
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agi...
Condition
Alzheimer Disease
Enrollment
600 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
NCT06625775 Phase 1
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
392 pts
Location
United States, Australia, France
Sponsor
TheRas, Inc., d/b/a BBOT (Brid
NCT04494295 N/A
Recruiting
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Condition
Supratentorial Hemorrhage
Enrollment
500 pts
Location
United States
Sponsor
Integra LifeSciences Corporati
NCT06685757 Phase 3
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in A...
Condition
Antibody-mediated Rejection
Enrollment
120 pts
Location
United States, Argentina, Australia
Sponsor
Biogen
NCT02660645 N/A
Recruiting
Blue Light Cystoscopy With Cysview® Registry
Condition
Bladder Cancer
Enrollment
4,400 pts
Location
United States
Sponsor
Photocure
NCT07364773 N/A
Recruiting
Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational...
Condition
Spinal Cord Injuries (SCI)
Enrollment
180 pts
Location
United States
Sponsor
Shirley Ryan AbilityLab
NCT06833073 Phase 2
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Ca...
Condition
Urinary Bladder Neoplasms
Enrollment
308 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05544266 N/A
Recruiting
Rare and Atypical Diabetes Network
Condition
Diabetes Mellitus
Enrollment
2,000 pts
Location
United States
Sponsor
University of South Florida
NCT06368817 Phase 2
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Condition
Basal Ganglia Germinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07285018 Phase 2
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
150 pts
Location
United States, Puerto Rico
Sponsor
Eli Lilly and Company
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer